Politics / Canada
Health Canada Approves Generic Ozempic
Health Canada has approved the first generic version of Ozempic, a medication primarily for Type 2 diabetes that is also widely used for weight loss. This approval is expected to significantly reduce costs for consumers, with projections indicating a drop from around $7.20 to $3 per day.
Source material: Health Canada approves 1st generic version of Ozempic drug | Hanomansing Tonight
Summary
Health Canada has approved the first generic version of Ozempic, a medication primarily for Type 2 diabetes that is also widely used for weight loss. This approval is expected to significantly reduce costs for consumers, with projections indicating a drop from around $7.20 to $3 per day.
Canada becomes the first G7 nation to approve this generic version after the original patent from Novo Nordisk expired in January. The approval process for eight additional generic applications is currently underway, which may lead to further price reductions for consumers.
The generic Ozempic is manufactured by Dr. Reddy, an Indian company that has also gained approval from health authorities in India. This development highlights the potential for increased competition in the market, which could further drive down prices.
Perspectives
Support for Generic Approval
- Anticipates significant cost reductions for consumers
- Encourages market competition leading to lower prices
Concerns Over Market Impact
- Questions remain about the actual impact on accessibility
Neutral / Shared
- Health Canada is reviewing additional generic applications
- Dr. Reddy is the first manufacturer to receive approval
Metrics
$7.20 USD
original price per day of Ozempic
This price point highlights the financial burden on patients prior to the generic approval
$7.20 a day
Key entities
Key developments
Phase 1
Health Canada has approved the first generic version of Ozempic, a medication primarily for Type 2 diabetes that is also widely used for weight loss. This approval is expected to significantly reduce costs for consumers, with projections indicating a drop from around $7.20 to $3 per day.
- Health Canada has approved the first generic version of Ozempic, a medication primarily for Type 2 diabetes that is also widely used for weight loss
- This approval is anticipated to significantly reduce costs, with projections indicating a drop from around $7.20 to $3 per day
- Canada becomes the first G7 nation to approve this generic version after the original patent from Novo Nordisk expired in January
- The approval process for eight additional generic applications is currently underway, which may lead to further price reductions for consumers
- The generic Ozempic is manufactured by Dr. Reddy, an Indian company that has also gained approval from health authorities in India